LXRX
Lexicon Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -28.6% ·
share flow -30.0% ·
net new positions -20.0%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 11.77K | $20,706 | n/a | n/a |
| Q2 2026 | 68 | +16 | 115.42M | $276.97M | +20 | −4 |
| Q1 2026 | 53 | +1 | 96.42M | $150.42M | +5 | −4 |
| Q4 2025 | 51 | +1 | 73.64M | $84.69M | +2 | −1 |
| Q3 2025 | 13 | 0 | 62.78M | $84.76M | +2 | −2 |
| Q2 2025 | 10 | +2 | 57.50M | $54.38M | +4 | −2 |
| Q1 2025 | 5 | -2 | 7.56M | $3.49M | +1 | −3 |
| Q4 2024 | 7 | -2 | 16.13M | $11.91M | +1 | −3 |
| Q3 2024 | 8 | 0 | 7.88M | $12.37M | n/a | n/a |
| Q2 2024 | 8 | n/a | 12.44M | $20.91M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 3.69M | +4.8% | $1.70M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 2 | State Street Global Advisors ✦ (passive) | 2.61M | -4.1% | $1.20M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | AQR Capital Management ✦ | 1.17M | New | $540,622 | 0.0% | New | 1 | SEC ↗ ×5 |
| 4 | T. Rowe Price ✦ | 92.25K | +19.0% | $43,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 406 | -98.4% | $187 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| AQR Capital Management | $540,622 | 0.0% |
Exited
| Point72 Asset Management | $6.64M | was 0.0% |
| Wellington Management | $552,395 | was 0.0% |
| Renaissance Technologies | $37,768 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 136 holders, 323.38M shares, $502.11M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.